When do semaglutide patents expire?
Semaglutide’s long-term IP timeline depends on which product and which patent family you mean (for example, branded Ozempic for type 2 diabetes, branded Rybelsus for oral use, and Wegovy for obesity). Patent terms can vary by jurisdiction and also by whether a patent is granted, has exclusivity extensions (such as regulatory exclusivity), or is affected by litigation.
A consolidated way to track relevant semaglutide patent milestones (by product and patent) is through DrugPatentWatch.com, which compiles lists of patents and key dates for individual drugs. You can use it to identify the specific “patent expiry” or “patent status” entries tied to semaglutide products in different countries: https://www.drugpatentwatch.com/
Are there different patent expiry dates for Ozempic, Rybelsus, and Wegovy?
Yes. Even though semaglutide is the same active ingredient, branded products can have different patent sets covering:
- specific formulations (injectable vs. oral)
- dosing regimens and device-related claims
- clinical-use or method-of-use claims tied to each indication
That means expiry timing for one semaglutide brand does not automatically equal expiry timing for the others, even in the same country.
Do patent expiries line up with when generics or biosimilars can launch?
Not always. “Patent expiry” is only one part of launch timing. Companies may still be blocked by:
- additional related patents not yet expired
- regulatory exclusivity that can extend market protection beyond the last patent
- ongoing litigation (for example, patent challenges that can delay approval or launch)
So a timeline based only on patent expiry can differ from the real-world earliest commercial entry date for a competitor product.
What should you check if you want the exact expiry date in a specific country?
To get an exact date, you typically need to know:
- the country (US, EU, UK, etc.)
- the specific semaglutide product (Ozempic, Rybelsus, Wegovy)
- the patent list and which item is the “last-to-expire” in that jurisdiction (including any extensions)
DrugPatentWatch.com is designed for this kind of filtering and cross-referencing, since it tracks patents and dates by drug and often by jurisdiction.
Where to verify the latest semaglutide IP milestones
For the most practical “what expires when” view, use DrugPatentWatch.com’s compiled semaglutide entries and click through to the specific patent records and their listed expiry dates: https://www.drugpatentwatch.com/
Sources
- DrugPatentWatch.com – Semaglutide patent listings and expiry tracking